Abstract
The primary aim of this study was to evaluate the feasibility of Strata XRT in the treatment of radiation dermatitis in head and neck cancer patients compared to the use of the department’s standard of practice; Fatty E Cream. This study was undertaken to gather both the healthcare professional and the patient’s perspective on the use of Strata XRT. Data collection was completed retrospectively for the control patients and prospectively for the study patients. Data was collected through the use of weekly adjusted RIS RAS scoring assessments and CTCAE assessments of patients using Fatty E cream or Strata XRT. Adjusted RIS RAS scores also collected data on patient tolerability, compliance and usage of Strata XRT. Results suggest patients find Strata XRT easy and comfortable to use although can be sticky and painful to apply. An average of 2.7 50g tubes were required for bilateral nodal patients and 1.8 tubes for patients with no nodal irradiation. Strata XRT is feasible if the healthcare provider uses a value-based economic system compared with a cost-effectiveness system.